Fluorescite Intravenous Injection 500mg (Fluorescein Vials) 500mg/5mL

Fluorescite Intravenous Injection 500mg contains fluorescein for diagnostic imaging. Used in ophthalmology to highlight blood vessels in the retina. Administered via intravenous injection for enhanced visualization. Store at room temperature in original packaging.

Strength

500mg/5mL

Pack Size

12s

Storage

Ambient

Manufacturer / TM Owner

Novartis

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fluorescite Intravenous Injection 500mg is used during fluorescein angiography to examine blood flow in the retina and choroid. It helps identify abnormalities such as blockages, leaks, or abnormal vessel growth. The 500mg strength provides clear contrast for detailed imaging in eye examinations.

Side Effects

After injection, fluorescein circulates through the blood vessels in the eye, temporarily highlighting them for imaging. The dye may cause a brief yellowish tint to skin and urine, which is normal and resolves over time. Some individuals may experience mild nausea or dizziness immediately after administration.

Precautions & Warnings

Avoid use if allergic to fluorescein or any component of the injection. Inform your healthcare provider of any kidney or liver conditions before administration. Pregnant or breastfeeding individuals should consult a doctor prior to use. Ensure the injection site is clean and properly monitored post-administration.

Avoid Interactions

Fluorescite may interact with medications affecting kidney function, such as diuretics or certain antibiotics. Alcohol and sedatives can enhance dizziness post-injection. No known direct interactions with common over-the-counter supplements, but disclose all medications to your healthcare provider.

Frequently Asked Questions

It is used during fluorescein angiography to visualize blood vessels in the retina and choroid for diagnostic purposes.

It is administered as an intravenous injection by a healthcare professional during an eye examination.

Common effects include temporary yellowish skin or urine discoloration and mild nausea or dizziness.

Consult a healthcare provider before use if pregnant or breastfeeding to assess potential risks.

Store at room temperature in the original packaging and protect from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.